Clinical Trial: Study of GBT021601 in Participants With Renal Impairment
Study Status: Completed
Recruit Status: RECRUITING
Condition: Renal Impairment
Study Type: INTERVENTIONAL
Official Title: A Phase I, Open-Label, Single-Dose, Non-Randomized, Parallel Group Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of GBT021601, an Oral Hemoglobin S Polymerization Inhibitor, in Adul
Brief Summary:
Renal Impairment study of GBT021601.
Read more